SEC Form 4 · accession 0001493152-16-015241
Adhera Therapeutics, Inc. · ATRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph W. Ramelli
Officer — Interim CEO · Director
Period of report
Nov 15, 2016
Accepted (ET)
Nov 17, 2016 · 5:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000737207
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to purchase common stock | $0.10 | Nov 15, 2016 | A | 35,000 | A | Nov 15, 2016 | Nov 15, 2021 | Common stock | 35,000 | 35,000 | D |